lidocaine has been researched along with Bladder, Overactive in 15 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 5.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "To compare pain scores with preprocedure oral phenazopyridine vs intravesical lidocaine in women undergoing intradetrusor onabotulinumtoxinA injections for idiopathic overactive bladder." | 5.51 | Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial. ( Jacobs, KM; Raker, CA; Siddique, M; Stewart, LE; Sung, VW, 2022) |
| "Patients suffering from urge syndrome with and without urge incontinence and non-responding to oral anticholinergic drugs underwent EMDA therapy (2000 mg lidocaine-HCl 4% (50 ml), 2 mg epinephrine [1:1000] (2 ml), 40 mg dexamethason-21-dihydrogen phosphat (10 ml) in a total volume of 100 ml)." | 3.75 | Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity. ( Bach, P; Goepel, M; Möhring, C; Wormland, RT, 2009) |
| "Sedation-free intradetrusor botulinum toxin-A injection using intravesical lidocaine and flexible endoscopy is a well tolerated and safe procedure to perform in an office setting." | 2.73 | Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. ( Barboglio, P; Cohen, BL; Gousse, A; Rivera, R, 2007) |
| "The treatment of patients with overactive bladder (OAB) refractory to conventional treatment is gaining clinical significance." | 2.47 | [Therapy-refractory overactive bladder: alternative treatment approaches]. ( Hamann, M; Jünemann, KP; Knüpfer, S; Melchior, D; Naumann, CM, 2011) |
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 1.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "Lidocaine is a common local anesthetic and antiarrhythmic drug that acts via the local anesthetic effect of blocking voltage-gated sodium channels in peripheral neurons." | 1.56 | Effects of 1% Lidocaine Instillation on Overactive Bladder Induced by Bladder Outlet Obstruction in Rats. ( Han, SW; Kang, HJ; Kim, JH; Kim, SW; Lee, YS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Stewart, LE | 1 |
| Siddique, M | 1 |
| Jacobs, KM | 1 |
| Raker, CA | 1 |
| Sung, VW | 1 |
| Faure Walker, N | 3 |
| Macpherson, F | 3 |
| Tasleem, A | 3 |
| Rampal, T | 3 |
| Raisin, G | 1 |
| Dothan, D | 1 |
| Perez, D | 1 |
| Ala-Adin, N | 1 |
| Kafka, I | 1 |
| Shenfeld, O | 1 |
| Hatumi, S | 1 |
| Malchi, N | 1 |
| Gordon, A | 1 |
| Touitou, D | 1 |
| Moldwin, R | 1 |
| Nassar, T | 1 |
| Chertin, B | 1 |
| Kang, HJ | 1 |
| Kim, SW | 1 |
| Lee, YS | 1 |
| Han, SW | 1 |
| Kim, JH | 1 |
| Hermieu, JF | 1 |
| Ballanger, P | 1 |
| Amarenco, G | 1 |
| Chartier-Kastler, E | 1 |
| Cosson, M | 1 |
| Costa, P | 1 |
| Fatton, B | 1 |
| Deffieux, X | 1 |
| Denys, P | 1 |
| Gamé, X | 1 |
| Haab, F | 1 |
| Karsenty, G | 1 |
| Le Normand, L | 1 |
| Ruffion, A | 1 |
| Saussine, C | 1 |
| Tamam, Y | 1 |
| Özdemir, HH | 1 |
| Gedik, A | 1 |
| Tamam, C | 1 |
| Nazlıkul, H | 1 |
| Mitra, R | 1 |
| Huang, L | 1 |
| Payne, C | 1 |
| Bach, P | 1 |
| Wormland, RT | 1 |
| Möhring, C | 1 |
| Goepel, M | 1 |
| Juszczak, K | 2 |
| Ziomber, A | 1 |
| Wyczolkowski, M | 1 |
| Thor, PJ | 2 |
| Knüpfer, S | 1 |
| Hamann, M | 1 |
| Naumann, CM | 1 |
| Melchior, D | 1 |
| Jünemann, KP | 1 |
| Furuta, A | 1 |
| Suzuki, Y | 1 |
| Honda, M | 1 |
| Koike, Y | 1 |
| Naruoka, T | 1 |
| Asano, K | 1 |
| Chancellor, M | 1 |
| Egawa, S | 1 |
| Yoshimura, N | 1 |
| Cohen, BL | 1 |
| Rivera, R | 1 |
| Barboglio, P | 1 |
| Gousse, A | 1 |
| Roxburgh, C | 2 |
| Cook, J | 2 |
| Dublin, N | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral Phenazopyridine Versus Intravesical Lidocaine for Office OnabotulinumtoxinA Analgesia: A Randomized Controlled Trial[NCT03755089] | Phase 4 | 110 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting | ||
| Effectiveness of HYPNOsis Masks in the Management of Pain and Anxiety During Botulinum TOXin Injections in the Treatment of Idiopathic Overactive Bladder: a Multicenter Randomized Parallel Group Study.[NCT05352945] | 70 participants (Anticipated) | Interventional | 2022-06-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for lidocaine and Bladder, Overactive
| Article | Year |
|---|---|
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Humans; Lidocaine; Neuro | 2023 |
[Therapy-refractory overactive bladder: alternative treatment approaches].
Topics: Administration, Intravesical; Botulinum Toxins, Type A; Cholinergic Antagonists; Complementary Thera | 2011 |
[Capsaicin and lidocaine usage in functional disorders of urinary bladder].
Topics: Botulinum Toxins; Calcium Channels; Capsaicin; Cholinergic Antagonists; Drug Therapy, Combination; H | 2011 |
Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Cholinergic Antagonists; Dopamine Uptake | 2007 |
Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Cholinergic Antagonists; Dopamine Uptake | 2007 |
2 trials available for lidocaine and Bladder, Overactive
| Article | Year |
|---|---|
Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial.
Topics: Adult; Analgesia; Botulinum Toxins, Type A; Female; Humans; Lidocaine; Pain; Phenazopyridine; Treatm | 2022 |
Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.
Topics: Administration, Intravesical; Anesthetics, Local; Botulinum Toxins, Type A; Cystoscopy; Female; Huma | 2007 |
8 other studies available for lidocaine and Bladder, Overactive
| Article | Year |
|---|---|
Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St
Topics: Administration, Intravesical; Cystitis, Interstitial; Delayed-Action Preparations; Humans; Lidocaine | 2023 |
Effects of 1% Lidocaine Instillation on Overactive Bladder Induced by Bladder Outlet Obstruction in Rats.
Topics: Administration, Intravesical; Anesthetics, Local; Animals; Disease Models, Animal; Female; Lidocaine | 2020 |
[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management].
Topics: Administration, Intravesical; Anesthetics, Local; Antibiotic Prophylaxis; Anticoagulants; Botulinum | 2013 |
Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients.
Topics: Adult; Anesthetics, Local; Female; Humans; Injections, Epidural; Injections, Intradermal; Lidocaine; | 2017 |
Epidural steroid injections in the management of a patient with spinal stenosis and urinary urgency.
Topics: Aged; Disease Management; Female; Humans; Injections, Epidural; Lidocaine; Lumbar Vertebrae; Spinal | 2009 |
Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents; Cholinergic Antagonists; Deamino Arginine Vasopr | 2009 |
Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
Topics: Administration, Intravesical; Afferent Pathways; Anesthetics, Local; Animals; Capsaicin; Cystitis; D | 2009 |
Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus.
Topics: Anesthetics, Local; Animals; Case-Control Studies; Chronic Pain; Disease Models, Animal; Female; Fib | 2012 |